Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

Open Access 01-01-2014 | Editorial

Is nano too big?

Authors: Walter Mier, John Babich, Uwe Haberkorn

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2014

Excerpt

The possibility to utilize nanotechnology for drug development has led to widespread interest and funding opportunities. The public perception of the field of nanoscale science originally referred to technologies dealing with nanomechanics, nanomaterials, nanooptics and nanoelectronics, but increasingly anticipates progress in nanomedicine. Today’s molecular imaging possibilities are ideal for visualizing the pharmacokinetics of the effectors used in new treatment strategies such as gene therapy [1] and therapeutic vaccination [2]. With the possibility to visualize and the salient, concomitant treatment, nuclear medicine has the greatest potential for use in the development of innovative treatment strategies. Consequently, the eventual applications of nanosized tracers are of the greatest interest for our discipline. …

Penuelas I, Haberkorn U, Yaghoubi S, Gambhir SS. Gene therapy imaging in patients for oncological applications. Eur J Nucl Med Mol Imaging. 2005;32 Suppl 2:S384–403. doi:10.1007/s00259-005-1928-3.PubMedCrossRef

Muthuswamy R, Mueller-Berghaus J, Haberkorn U, Reinhart TA, Schadendorf D, Kalinski P. PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood. 2010;116:1454–9. doi:10.1182/blood-2009-12-258038.PubMedCrossRef

Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology. 2011;54:868–78. doi:10.1002/hep.24451.PubMedCrossRef

Lovrics PJ, Cornacchi SD, Vora R, Goldsmith CH, Kahnamoui K. Systematic review of radioguided surgery for non-palpable breast cancer. Eur J Surg Oncol. 2011;37:388–97. doi:10.1016/j.ejso.2011.01.018.PubMedCrossRef

O’Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol. 2004;15:440–9.PubMedCrossRef

Hulsermann U, Hoffmann MM, Massing U, Fricker G. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries. J Drug Target. 2009;17:610–8. doi:10.1080/10611860903105986.PubMedCrossRef

Alexis F, Pridgen EM, Langer R, Farokhzad OC. Nanoparticle technologies for cancer therapy. Handb Exp Pharmacol. 2010;(197):55–86. doi:10.1007/978-3-642-00477-3_2

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26.PubMedCrossRef

Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583–92. doi:10.1038/nrc1893.PubMedCrossRef

10.

Dennis MS, Jin H, Dugger D, Yang R, McFarland L, Ogasawara A, et al. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent. Cancer Res. 2007;67:254–61. doi:10.1158/0008-5472.CAN-06-2531.PubMedCrossRef

11.

Mier W, Hoffend J, Kramer S, Schuhmacher J, Hull WE, Eisenhut M, et al. Conjugation of DOTA using isolated phenolic active esters: the labeling and biodistribution of albumin as blood pool marker. Bioconjug Chem. 2005;16:237–40. doi:10.1021/bc034216c.PubMedCrossRef

Title: Is nano too big?
Authors: Walter Mier
John Babich
Uwe Haberkorn
Publication date: 01-01-2014
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-013-2574-9

At a glance: The STEP trials

Springer Medicine

Is nano too big?

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2014

Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

Writing PET into existence

Quantitative myocardial blood flow imaging: not all flow is equal

Combined 99mTc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules

Nuclear medicine training and practice in Germany

Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching